Abstract
Get full access to this article
View all access options for this article.
References
1.Rare Diseases , NIH , November 2023
2.Rare disease emerging as a global public health priority , October 2022
3.
Abeona Therapeutics Announces Licensing of the AIM™ Next Generation AAV Gene Therapy Vector Platform From The University of North Carolina at Chapel Hill, September 2016
4.Bespoke Gene Therapy Consortium , June 2023
5.
Abeona Therapeutics and Taysha Gene Therapies Enter into Lic ensing and Inventory Purchase Agreements for ABO-202, a Clinical Stage, Novel, One-time Gene Therapy for CLN1 Disease, August 2020
6.
Joint Statement to the Global Batten Disease Community, February 2024